Medical Care
Global Mantle Cell Lymphoma Treatment Market Research Report 2025
- Mar 11, 25
- ID: 9255
- Pages: 82
- Figures: 88
- Views: 20
The global market for Mantle Cell Lymphoma Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mantle Cell Lymphoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mantle Cell Lymphoma Treatment.
The Mantle Cell Lymphoma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mantle Cell Lymphoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mantle Cell Lymphoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.
Segment by Type
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mantle Cell Lymphoma Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mantle Cell Lymphoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mantle Cell Lymphoma Treatment.
The Mantle Cell Lymphoma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mantle Cell Lymphoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mantle Cell Lymphoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.
Segment by Type
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mantle Cell Lymphoma Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Acalabrutinib
1.2.3 JCAR-017
1.2.4 JNJ-64052781
1.2.5 Acalisib
1.2.6 IGN-002
1.2.7 IMGN-529
1.2.8 AFM-11
1.2.9 Others
1.3 Market by Application
1.3.1 Global Mantle Cell Lymphoma Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mantle Cell Lymphoma Treatment Market Perspective (2020-2031)
2.2 Global Mantle Cell Lymphoma Treatment Growth Trends by Region
2.2.1 Global Mantle Cell Lymphoma Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mantle Cell Lymphoma Treatment Historic Market Size by Region (2020-2025)
2.2.3 Mantle Cell Lymphoma Treatment Forecasted Market Size by Region (2026-2031)
2.3 Mantle Cell Lymphoma Treatment Market Dynamics
2.3.1 Mantle Cell Lymphoma Treatment Industry Trends
2.3.2 Mantle Cell Lymphoma Treatment Market Drivers
2.3.3 Mantle Cell Lymphoma Treatment Market Challenges
2.3.4 Mantle Cell Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue
3.1.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue (2020-2025)
3.1.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mantle Cell Lymphoma Treatment Revenue
3.4 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Treatment Revenue in 2024
3.5 Global Key Players of Mantle Cell Lymphoma Treatment Head office and Area Served
3.6 Global Key Players of Mantle Cell Lymphoma Treatment, Product and Application
3.7 Global Key Players of Mantle Cell Lymphoma Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mantle Cell Lymphoma Treatment Breakdown Data by Type
4.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Type (2020-2025)
4.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2026-2031)
5 Mantle Cell Lymphoma Treatment Breakdown Data by Application
5.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Application (2020-2025)
5.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mantle Cell Lymphoma Treatment Market Size (2020-2031)
6.2 North America Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)
6.4 North America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mantle Cell Lymphoma Treatment Market Size (2020-2031)
7.2 Europe Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)
7.4 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size (2020-2031)
8.2 Asia-Pacific Mantle Cell Lymphoma Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mantle Cell Lymphoma Treatment Market Size (2020-2031)
9.2 Latin America Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)
9.4 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size (2020-2031)
10.2 Middle East & Africa Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals, Inc.
11.1.1 Astex Pharmaceuticals, Inc. Company Details
11.1.2 Astex Pharmaceuticals, Inc. Business Overview
11.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Introduction
11.1.4 Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.1.5 Astex Pharmaceuticals, Inc. Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Mantle Cell Lymphoma Treatment Introduction
11.2.4 Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.2.5 Bayer AG Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Details
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Introduction
11.4.4 Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.4.5 Celgene Corporation Recent Development
11.5 Cellular Biomedicine Group, Inc.
11.5.1 Cellular Biomedicine Group, Inc. Company Details
11.5.2 Cellular Biomedicine Group, Inc. Business Overview
11.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Introduction
11.5.4 Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.5.5 Cellular Biomedicine Group, Inc. Recent Development
11.6 Eisai
11.6.1 Eisai Company Details
11.6.2 Eisai Business Overview
11.6.3 Eisai Mantle Cell Lymphoma Treatment Introduction
11.6.4 Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.6.5 Eisai Recent Development
11.7 EpiZyme, Inc.
11.7.1 EpiZyme, Inc. Company Details
11.7.2 EpiZyme, Inc. Business Overview
11.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Introduction
11.7.4 EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.7.5 EpiZyme, Inc. Recent Development
11.8 Fate Therapeutics, Inc.
11.8.1 Fate Therapeutics, Inc. Company Details
11.8.2 Fate Therapeutics, Inc. Business Overview
11.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Introduction
11.8.4 Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.8.5 Fate Therapeutics, Inc. Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Details
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Introduction
11.9.4 Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.9.5 Genentech, Inc. Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Details
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.10.5 Gilead Sciences, Inc. Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Details
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.11.5 GlaxoSmithKline Plc Recent Development
11.12 Hutchison MediPharma Limited
11.12.1 Hutchison MediPharma Limited Company Details
11.12.2 Hutchison MediPharma Limited Business Overview
11.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Introduction
11.12.4 Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.12.5 Hutchison MediPharma Limited Recent Development
11.13 ImmunoGen, Inc.
11.13.1 ImmunoGen, Inc. Company Details
11.13.2 ImmunoGen, Inc. Business Overview
11.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Introduction
11.13.4 ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.13.5 ImmunoGen, Inc. Recent Development
11.14 Immunomedics, Inc.
11.14.1 Immunomedics, Inc. Company Details
11.14.2 Immunomedics, Inc. Business Overview
11.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Introduction
11.14.4 Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.14.5 Immunomedics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Acalabrutinib
1.2.3 JCAR-017
1.2.4 JNJ-64052781
1.2.5 Acalisib
1.2.6 IGN-002
1.2.7 IMGN-529
1.2.8 AFM-11
1.2.9 Others
1.3 Market by Application
1.3.1 Global Mantle Cell Lymphoma Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mantle Cell Lymphoma Treatment Market Perspective (2020-2031)
2.2 Global Mantle Cell Lymphoma Treatment Growth Trends by Region
2.2.1 Global Mantle Cell Lymphoma Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mantle Cell Lymphoma Treatment Historic Market Size by Region (2020-2025)
2.2.3 Mantle Cell Lymphoma Treatment Forecasted Market Size by Region (2026-2031)
2.3 Mantle Cell Lymphoma Treatment Market Dynamics
2.3.1 Mantle Cell Lymphoma Treatment Industry Trends
2.3.2 Mantle Cell Lymphoma Treatment Market Drivers
2.3.3 Mantle Cell Lymphoma Treatment Market Challenges
2.3.4 Mantle Cell Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue
3.1.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue (2020-2025)
3.1.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mantle Cell Lymphoma Treatment Revenue
3.4 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Treatment Revenue in 2024
3.5 Global Key Players of Mantle Cell Lymphoma Treatment Head office and Area Served
3.6 Global Key Players of Mantle Cell Lymphoma Treatment, Product and Application
3.7 Global Key Players of Mantle Cell Lymphoma Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mantle Cell Lymphoma Treatment Breakdown Data by Type
4.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Type (2020-2025)
4.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2026-2031)
5 Mantle Cell Lymphoma Treatment Breakdown Data by Application
5.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Application (2020-2025)
5.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mantle Cell Lymphoma Treatment Market Size (2020-2031)
6.2 North America Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)
6.4 North America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mantle Cell Lymphoma Treatment Market Size (2020-2031)
7.2 Europe Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)
7.4 Europe Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size (2020-2031)
8.2 Asia-Pacific Mantle Cell Lymphoma Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mantle Cell Lymphoma Treatment Market Size (2020-2031)
9.2 Latin America Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)
9.4 Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size (2020-2031)
10.2 Middle East & Africa Mantle Cell Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals, Inc.
11.1.1 Astex Pharmaceuticals, Inc. Company Details
11.1.2 Astex Pharmaceuticals, Inc. Business Overview
11.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Introduction
11.1.4 Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.1.5 Astex Pharmaceuticals, Inc. Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Mantle Cell Lymphoma Treatment Introduction
11.2.4 Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.2.5 Bayer AG Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Details
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Introduction
11.4.4 Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.4.5 Celgene Corporation Recent Development
11.5 Cellular Biomedicine Group, Inc.
11.5.1 Cellular Biomedicine Group, Inc. Company Details
11.5.2 Cellular Biomedicine Group, Inc. Business Overview
11.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Introduction
11.5.4 Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.5.5 Cellular Biomedicine Group, Inc. Recent Development
11.6 Eisai
11.6.1 Eisai Company Details
11.6.2 Eisai Business Overview
11.6.3 Eisai Mantle Cell Lymphoma Treatment Introduction
11.6.4 Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.6.5 Eisai Recent Development
11.7 EpiZyme, Inc.
11.7.1 EpiZyme, Inc. Company Details
11.7.2 EpiZyme, Inc. Business Overview
11.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Introduction
11.7.4 EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.7.5 EpiZyme, Inc. Recent Development
11.8 Fate Therapeutics, Inc.
11.8.1 Fate Therapeutics, Inc. Company Details
11.8.2 Fate Therapeutics, Inc. Business Overview
11.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Introduction
11.8.4 Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.8.5 Fate Therapeutics, Inc. Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Details
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Introduction
11.9.4 Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.9.5 Genentech, Inc. Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Details
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.10.5 Gilead Sciences, Inc. Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Details
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.11.5 GlaxoSmithKline Plc Recent Development
11.12 Hutchison MediPharma Limited
11.12.1 Hutchison MediPharma Limited Company Details
11.12.2 Hutchison MediPharma Limited Business Overview
11.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Introduction
11.12.4 Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.12.5 Hutchison MediPharma Limited Recent Development
11.13 ImmunoGen, Inc.
11.13.1 ImmunoGen, Inc. Company Details
11.13.2 ImmunoGen, Inc. Business Overview
11.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Introduction
11.13.4 ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.13.5 ImmunoGen, Inc. Recent Development
11.14 Immunomedics, Inc.
11.14.1 Immunomedics, Inc. Company Details
11.14.2 Immunomedics, Inc. Business Overview
11.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Introduction
11.14.4 Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025)
11.14.5 Immunomedics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Acalabrutinib
Table 3. Key Players of JCAR-017
Table 4. Key Players of JNJ-64052781
Table 5. Key Players of Acalisib
Table 6. Key Players of IGN-002
Table 7. Key Players of IMGN-529
Table 8. Key Players of AFM-11
Table 9. Global Mantle Cell Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Mantle Cell Lymphoma Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Mantle Cell Lymphoma Treatment Market Share by Region (2020-2025)
Table 13. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Mantle Cell Lymphoma Treatment Market Share by Region (2026-2031)
Table 15. Mantle Cell Lymphoma Treatment Market Trends
Table 16. Mantle Cell Lymphoma Treatment Market Drivers
Table 17. Mantle Cell Lymphoma Treatment Market Challenges
Table 18. Mantle Cell Lymphoma Treatment Market Restraints
Table 19. Global Mantle Cell Lymphoma Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Mantle Cell Lymphoma Treatment Market Share by Players (2020-2025)
Table 21. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2024)
Table 22. Ranking of Global Top Mantle Cell Lymphoma Treatment Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Mantle Cell Lymphoma Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Mantle Cell Lymphoma Treatment, Headquarters and Area Served
Table 25. Global Key Players of Mantle Cell Lymphoma Treatment, Product and Application
Table 26. Global Key Players of Mantle Cell Lymphoma Treatment, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Mantle Cell Lymphoma Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2020-2025)
Table 30. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2026-2031)
Table 32. Global Mantle Cell Lymphoma Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2020-2025)
Table 34. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2026-2031)
Table 36. North America Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 51. Astex Pharmaceuticals, Inc. Company Details
Table 52. Astex Pharmaceuticals, Inc. Business Overview
Table 53. Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Product
Table 54. Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 55. Astex Pharmaceuticals, Inc. Recent Development
Table 56. Bayer AG Company Details
Table 57. Bayer AG Business Overview
Table 58. Bayer AG Mantle Cell Lymphoma Treatment Product
Table 59. Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 60. Bayer AG Recent Development
Table 61. Bristol-Myers Squibb Company Company Details
Table 62. Bristol-Myers Squibb Company Business Overview
Table 63. Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product
Table 64. Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 65. Bristol-Myers Squibb Company Recent Development
Table 66. Celgene Corporation Company Details
Table 67. Celgene Corporation Business Overview
Table 68. Celgene Corporation Mantle Cell Lymphoma Treatment Product
Table 69. Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 70. Celgene Corporation Recent Development
Table 71. Cellular Biomedicine Group, Inc. Company Details
Table 72. Cellular Biomedicine Group, Inc. Business Overview
Table 73. Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Product
Table 74. Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 75. Cellular Biomedicine Group, Inc. Recent Development
Table 76. Eisai Company Details
Table 77. Eisai Business Overview
Table 78. Eisai Mantle Cell Lymphoma Treatment Product
Table 79. Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 80. Eisai Recent Development
Table 81. EpiZyme, Inc. Company Details
Table 82. EpiZyme, Inc. Business Overview
Table 83. EpiZyme, Inc. Mantle Cell Lymphoma Treatment Product
Table 84. EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 85. EpiZyme, Inc. Recent Development
Table 86. Fate Therapeutics, Inc. Company Details
Table 87. Fate Therapeutics, Inc. Business Overview
Table 88. Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Product
Table 89. Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 90. Fate Therapeutics, Inc. Recent Development
Table 91. Genentech, Inc. Company Details
Table 92. Genentech, Inc. Business Overview
Table 93. Genentech, Inc. Mantle Cell Lymphoma Treatment Product
Table 94. Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 95. Genentech, Inc. Recent Development
Table 96. Gilead Sciences, Inc. Company Details
Table 97. Gilead Sciences, Inc. Business Overview
Table 98. Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Product
Table 99. Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 100. Gilead Sciences, Inc. Recent Development
Table 101. GlaxoSmithKline Plc Company Details
Table 102. GlaxoSmithKline Plc Business Overview
Table 103. GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Product
Table 104. GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 105. GlaxoSmithKline Plc Recent Development
Table 106. Hutchison MediPharma Limited Company Details
Table 107. Hutchison MediPharma Limited Business Overview
Table 108. Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Product
Table 109. Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 110. Hutchison MediPharma Limited Recent Development
Table 111. ImmunoGen, Inc. Company Details
Table 112. ImmunoGen, Inc. Business Overview
Table 113. ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Product
Table 114. ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 115. ImmunoGen, Inc. Recent Development
Table 116. Immunomedics, Inc. Company Details
Table 117. Immunomedics, Inc. Business Overview
Table 118. Immunomedics, Inc. Mantle Cell Lymphoma Treatment Product
Table 119. Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 120. Immunomedics, Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Mantle Cell Lymphoma Treatment Picture
Figure 2. Global Mantle Cell Lymphoma Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mantle Cell Lymphoma Treatment Market Share by Type: 2024 VS 2031
Figure 4. Acalabrutinib Features
Figure 5. JCAR-017 Features
Figure 6. JNJ-64052781 Features
Figure 7. Acalisib Features
Figure 8. IGN-002 Features
Figure 9. IMGN-529 Features
Figure 10. AFM-11 Features
Figure 11. Others Features
Figure 12. Global Mantle Cell Lymphoma Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Mantle Cell Lymphoma Treatment Market Share by Application: 2024 VS 2031
Figure 14. Hospital Case Studies
Figure 15. Clinic Case Studies
Figure 16. Others Case Studies
Figure 17. Mantle Cell Lymphoma Treatment Report Years Considered
Figure 18. Global Mantle Cell Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Mantle Cell Lymphoma Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Mantle Cell Lymphoma Treatment Market Share by Region: 2024 VS 2031
Figure 21. Global Mantle Cell Lymphoma Treatment Market Share by Players in 2024
Figure 22. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Mantle Cell Lymphoma Treatment Revenue in 2024
Figure 24. North America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)
Figure 26. United States Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)
Figure 30. Germany Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Mantle Cell Lymphoma Treatment Market Share by Region (2020-2031)
Figure 38. China Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)
Figure 46. Mexico Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)
Figure 50. Turkey Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Astex Pharmaceuticals, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 54. Bayer AG Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 56. Celgene Corporation Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 57. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 58. Eisai Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 59. EpiZyme, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 60. Fate Therapeutics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 61. Genentech, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 62. Gilead Sciences, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 63. GlaxoSmithKline Plc Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 64. Hutchison MediPharma Limited Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 65. ImmunoGen, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 66. Immunomedics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Acalabrutinib
Table 3. Key Players of JCAR-017
Table 4. Key Players of JNJ-64052781
Table 5. Key Players of Acalisib
Table 6. Key Players of IGN-002
Table 7. Key Players of IMGN-529
Table 8. Key Players of AFM-11
Table 9. Global Mantle Cell Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Mantle Cell Lymphoma Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Mantle Cell Lymphoma Treatment Market Share by Region (2020-2025)
Table 13. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Mantle Cell Lymphoma Treatment Market Share by Region (2026-2031)
Table 15. Mantle Cell Lymphoma Treatment Market Trends
Table 16. Mantle Cell Lymphoma Treatment Market Drivers
Table 17. Mantle Cell Lymphoma Treatment Market Challenges
Table 18. Mantle Cell Lymphoma Treatment Market Restraints
Table 19. Global Mantle Cell Lymphoma Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Mantle Cell Lymphoma Treatment Market Share by Players (2020-2025)
Table 21. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2024)
Table 22. Ranking of Global Top Mantle Cell Lymphoma Treatment Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Mantle Cell Lymphoma Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Mantle Cell Lymphoma Treatment, Headquarters and Area Served
Table 25. Global Key Players of Mantle Cell Lymphoma Treatment, Product and Application
Table 26. Global Key Players of Mantle Cell Lymphoma Treatment, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Mantle Cell Lymphoma Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2020-2025)
Table 30. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2026-2031)
Table 32. Global Mantle Cell Lymphoma Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2020-2025)
Table 34. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2026-2031)
Table 36. North America Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 51. Astex Pharmaceuticals, Inc. Company Details
Table 52. Astex Pharmaceuticals, Inc. Business Overview
Table 53. Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Product
Table 54. Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 55. Astex Pharmaceuticals, Inc. Recent Development
Table 56. Bayer AG Company Details
Table 57. Bayer AG Business Overview
Table 58. Bayer AG Mantle Cell Lymphoma Treatment Product
Table 59. Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 60. Bayer AG Recent Development
Table 61. Bristol-Myers Squibb Company Company Details
Table 62. Bristol-Myers Squibb Company Business Overview
Table 63. Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product
Table 64. Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 65. Bristol-Myers Squibb Company Recent Development
Table 66. Celgene Corporation Company Details
Table 67. Celgene Corporation Business Overview
Table 68. Celgene Corporation Mantle Cell Lymphoma Treatment Product
Table 69. Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 70. Celgene Corporation Recent Development
Table 71. Cellular Biomedicine Group, Inc. Company Details
Table 72. Cellular Biomedicine Group, Inc. Business Overview
Table 73. Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Product
Table 74. Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 75. Cellular Biomedicine Group, Inc. Recent Development
Table 76. Eisai Company Details
Table 77. Eisai Business Overview
Table 78. Eisai Mantle Cell Lymphoma Treatment Product
Table 79. Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 80. Eisai Recent Development
Table 81. EpiZyme, Inc. Company Details
Table 82. EpiZyme, Inc. Business Overview
Table 83. EpiZyme, Inc. Mantle Cell Lymphoma Treatment Product
Table 84. EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 85. EpiZyme, Inc. Recent Development
Table 86. Fate Therapeutics, Inc. Company Details
Table 87. Fate Therapeutics, Inc. Business Overview
Table 88. Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Product
Table 89. Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 90. Fate Therapeutics, Inc. Recent Development
Table 91. Genentech, Inc. Company Details
Table 92. Genentech, Inc. Business Overview
Table 93. Genentech, Inc. Mantle Cell Lymphoma Treatment Product
Table 94. Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 95. Genentech, Inc. Recent Development
Table 96. Gilead Sciences, Inc. Company Details
Table 97. Gilead Sciences, Inc. Business Overview
Table 98. Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Product
Table 99. Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 100. Gilead Sciences, Inc. Recent Development
Table 101. GlaxoSmithKline Plc Company Details
Table 102. GlaxoSmithKline Plc Business Overview
Table 103. GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Product
Table 104. GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 105. GlaxoSmithKline Plc Recent Development
Table 106. Hutchison MediPharma Limited Company Details
Table 107. Hutchison MediPharma Limited Business Overview
Table 108. Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Product
Table 109. Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 110. Hutchison MediPharma Limited Recent Development
Table 111. ImmunoGen, Inc. Company Details
Table 112. ImmunoGen, Inc. Business Overview
Table 113. ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Product
Table 114. ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 115. ImmunoGen, Inc. Recent Development
Table 116. Immunomedics, Inc. Company Details
Table 117. Immunomedics, Inc. Business Overview
Table 118. Immunomedics, Inc. Mantle Cell Lymphoma Treatment Product
Table 119. Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2020-2025) & (US$ Million)
Table 120. Immunomedics, Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Mantle Cell Lymphoma Treatment Picture
Figure 2. Global Mantle Cell Lymphoma Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mantle Cell Lymphoma Treatment Market Share by Type: 2024 VS 2031
Figure 4. Acalabrutinib Features
Figure 5. JCAR-017 Features
Figure 6. JNJ-64052781 Features
Figure 7. Acalisib Features
Figure 8. IGN-002 Features
Figure 9. IMGN-529 Features
Figure 10. AFM-11 Features
Figure 11. Others Features
Figure 12. Global Mantle Cell Lymphoma Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Mantle Cell Lymphoma Treatment Market Share by Application: 2024 VS 2031
Figure 14. Hospital Case Studies
Figure 15. Clinic Case Studies
Figure 16. Others Case Studies
Figure 17. Mantle Cell Lymphoma Treatment Report Years Considered
Figure 18. Global Mantle Cell Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Mantle Cell Lymphoma Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Mantle Cell Lymphoma Treatment Market Share by Region: 2024 VS 2031
Figure 21. Global Mantle Cell Lymphoma Treatment Market Share by Players in 2024
Figure 22. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Mantle Cell Lymphoma Treatment Revenue in 2024
Figure 24. North America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)
Figure 26. United States Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)
Figure 30. Germany Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Mantle Cell Lymphoma Treatment Market Share by Region (2020-2031)
Figure 38. China Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)
Figure 46. Mexico Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Mantle Cell Lymphoma Treatment Market Share by Country (2020-2031)
Figure 50. Turkey Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Mantle Cell Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Astex Pharmaceuticals, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 54. Bayer AG Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 56. Celgene Corporation Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 57. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 58. Eisai Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 59. EpiZyme, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 60. Fate Therapeutics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 61. Genentech, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 62. Gilead Sciences, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 63. GlaxoSmithKline Plc Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 64. Hutchison MediPharma Limited Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 65. ImmunoGen, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 66. Immunomedics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232